Matthew Korenberg - 05 Dec 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
PRESIDENT & CHIEF OPERATING
Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Octavio Espinoza
Issuer symbol
LGND
Transactions as of
05 Dec 2023
Transactions value $
-$118,266
Form type
4
Filing time
06 Dec 2023, 15:27:13 UTC
Previous filing
10 Jul 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$118,266 -1,984 -2% $59.61 97,140 05 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.